IDEAYA Announces First Patient In for Phase I Clinical Trial to Evaluate Darovasertib Monotherapy in Neo Adjuvant Uveal Melanoma

Tuesday, September 6, 2022 1 min read

Key Takeaway: IDEAYA Announces First Patient In for Phase I Clinical Trial to Evaluate Darovasertib Monotherapy in Neo Adjuvant Uveal Melanoma

Full Press Release Details

IDEAYA Announces First Patient In for Phase I Clinical Trial to Evaluate Darovasertib Monotherapy in Neo Adjuvant Uveal Melanoma.